Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma-Reference-Cited by-同舟云学术

Sequential Cytokine-Induced Killer Cell Immunotherapy Enhances the Efficacy of the Gemcitabine Plus Cisplatin Chemotherapy Regimen for Metastatic Nasopharyngeal Carcinoma

Published:2015-06-22 Issue:6 Volume:10 Page:e0130620
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Yin,Pan Ke,Liu Li-zhi,Li Yong-qiang,Gu Mo-fa,Zhang Hua,Shen Wei-xi,Xia Jian-chuan,Li Jian-jun

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. The role of chemotherapy in the management of nasopharyngeal carcinoma;AT Chan;Cancer,1998

2. Nasopharyngeal cancer: epidemiology, staging, and treatment;A Fandi;Semin Oncol,1994

3. Cancer mortality of Chinese in Canada;ZJ Wang;Int J Epidemiol,1989

4. Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma;BB Ma;Cancer,2002

5. Paclitaxel, Carboplatin, and Gemcitabine in MetastaticNasopharyngeal Carcinoma: a Phase II trial using a triplet combination;SS Leong;Cancer,2005

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for recurrent or metastatic nasopharyngeal carcinoma;npj Precision Oncology;2024-05-16

2. Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma – A Systematic Review and Meta-analysis;Oral Oncology;2024-05

3. How can Cytokine-induced killer cells overcome CAR-T cell limits;Frontiers in Immunology;2023-08-22

4. Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review);International Journal of Oncology;2023-07-05

5. Prognostic factor analysis in patients with early-stage nasopharyngeal carcinoma in the USA;Future Oncology;2023-05